Clinical

Dataset Information

0

Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus


ABSTRACT: RATIONALE: The Epstein Barr virus can cause cancer and lymphoproliferative disorders. Ganciclovir is an antiviral drug that acts against the Epstein Barr virus. Arginine butyrate may make virus cells more sensitive to ganciclovir. Combining ganciclovir and arginine butyrate may kill more Epstein Barr virus cells and tumor cells. PURPOSE: Phase I trial to study the effectiveness of arginine butyrate plus ganciclovir in treating patients who have cancer or lymphoproliferative disorders that are associated with the Epstein Barr virus.

DISEASE(S): Leukemia,Precancerous Condition,Small Intestine Cancer,Angioimmunoblastic T-cell Lymphoma,Precancerous Conditions,Lymphoma,Intestinal Neoplasms

PROVIDER: 2005372 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2015-10-14 | GSE71757 | GEO
| PRJNA483309 | ENA
2024-03-13 | GSE135794 | GEO
2023-09-15 | GSE234344 | GEO
| PRJNA817519 | ENA
2024-03-05 | PXD047528 | Pride
| PRJNA310351 | ENA
2023-09-01 | GSE226495 | GEO
| PRJNA533098 | ENA
| PRJNA1048420 | ENA